Note: This list contains duplicate records, as identified by the OpenAIRE deduplication algorithm based on metadata analysis.

PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases Terapevticheskii arkhiv · 2018 · 10.26442/terarkh201890927-30
PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases Terapevticheskii arkhiv · 2018 · 30701731